CASBF
Price
$6.60
Change
+$0.62 (+10.37%)
Updated
Sep 17 closing price
Capitalization
2.09B
CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.53B
Interact to see
Advertisement

CASBF vs CHSYF

Header iconCASBF vs CHSYF Comparison
Open Charts CASBF vs CHSYFBanner chart's image
CANSINO BIOLOGICS
Price$6.60
Change+$0.62 (+10.37%)
Volume$115
Capitalization2.09B
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.53B
CASBF vs CHSYF Comparison Chart in %
Loading...
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CASBF vs. CHSYF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CASBF is a Buy and CHSYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CASBF: $6.60 vs. CHSYF: $1.35)
Brand notoriety: CASBF and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CASBF: 63% vs. CHSYF: 48%
Market capitalization -- CASBF: $2.09B vs. CHSYF: $4.53B
CASBF [@Pharmaceuticals: Generic] is valued at $2.09B. CHSYF’s [@Pharmaceuticals: Generic] market capitalization is $4.53B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CASBF’s FA Score shows that 1 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • CASBF’s FA Score: 1 green, 4 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHSYF is a better buy in the long-term than CASBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CASBF’s TA Score shows that 2 TA indicator(s) are bullish while CHSYF’s TA Score has 0 bullish TA indicator(s).

  • CASBF’s TA Score: 2 bullish, 3 bearish.
  • CHSYF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, CHSYF is a better buy in the short-term than CASBF.

Price Growth

CASBF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CHSYF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.53B) has a higher market cap than CASBF($2.09B). CASBF YTD gains are higher at: 64.959 vs. CHSYF (45.052). CHSYF has higher annual earnings (EBITDA): 2.05B vs. CASBF (-1.88B). CHSYF has more cash in the bank: 5.97B vs. CASBF (4.02B). CHSYF has less debt than CASBF: CHSYF (748M) vs CASBF (2.12B). CHSYF has higher revenues than CASBF: CHSYF (7.86B) vs CASBF (359M).
CASBFCHSYFCASBF / CHSYF
Capitalization2.09B4.53B46%
EBITDA-1.88B2.05B-92%
Gain YTD64.95945.052144%
P/E RatioN/A14.06-
Revenue359M7.86B5%
Total Cash4.02B5.97B67%
Total Debt2.12B748M283%
FUNDAMENTALS RATINGS
CHSYF: Fundamental Ratings
CHSYF
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
43
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CASBFCHSYF
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
45%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
46%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
9%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
9%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
10%
View a ticker or compare two or three
Interact to see
Advertisement
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DOXGX277.97N/A
N/A
Dodge & Cox Stock X
JIGRX55.07N/A
N/A
Janus Henderson Overseas S
WMKGX25.56N/A
N/A
WesMark Large Company Fund
GVMCX48.90N/A
N/A
Government Street Opportunities
STREX22.19N/A
N/A
Sterling Capital Equity Income R6

CASBF and

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
-12.50%
CNTMF - CASBF
2%
Poorly correlated
N/A
BUDZ - CASBF
2%
Poorly correlated
-3.23%
CBWTF - CASBF
1%
Poorly correlated
-1.73%
CPHRF - CASBF
0%
Poorly correlated
+1.30%
More

CHSYF and

Correlation & Price change

A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
BSPK - CHSYF
9%
Poorly correlated
-6.90%
CANN - CHSYF
7%
Poorly correlated
-2.68%
CAIHF - CHSYF
0%
Poorly correlated
N/A
CASBF - CHSYF
0%
Poorly correlated
N/A
CANQF - CHSYF
-0%
Poorly correlated
N/A
More